Hull Sarah, Attanasio Marcella, Arno Gavin, Carss Keren, Robson Anthony G, Thompson Dorothy A, Plagnol Vincent, Michaelides Michel, Holder Graham E, Henderson Robert H, Raymond F Lucy, Moore Anthony T, Webster Andrew R
Moorfields Eye Hospital, London, England2University College London Institute of Ophthalmology, London, England.
Moorfields Eye Hospital, London, England3L'Unità Operativa di Oculistica, Ospedale Sacrocuore-Don Calabria, Negrar, Italy.
JAMA Ophthalmol. 2017 Feb 1;135(2):137-144. doi: 10.1001/jamaophthalmol.2016.5213.
There are limited published data on the phenotype of retinitis pigmentosa (RP) related to CNGB1 variants. These data are needed both for prognostic counseling of patients and for understanding potential treatment windows.
To describe the detailed clinical and molecular genetic findings in a series of patients with RP with likely pathogenic variants in CNGB1.
DESIGN, SETTING, AND PARTICIPANTS: In this case series, 10 patients from 9 families underwent full ophthalmologic examination. Molecular investigations included whole-exome analysis in 6 patients. The study was conducted from April 17, 2013, to March 3, 2016, with final follow-up completed on March 2, 2016, and data were analyzed from October 27, 2014, to March 29, 2016.
Results of ophthalmologic examination and molecular genetic analysis of CNGB1.
In this case series, 7 women and 3 men from 9 families with a mean (SD) age of 47.4 (13.2) years identified as having CNGB1 variants were included in this study; there was a mean (SD) follow-up length of 3.7 (2.8) years. The first clinical presentation was with nyctalopia in childhood with visual field loss documented later at a mean (SD) age of 33.2 (8.0) years. All patients had preserved best-corrected visual acuity into adulthood, with a mean of 0.1 logMAR (Snellen equivalent, 20/25) in each eye (logMAR range, 0.0 to 0.3 [Snellen 20/20 to 20/40] in the right eye and -0.1 to 0.3 [Snellen 20/16 to 20/40] in the left eye). Fundus examination revealed midperipheral retinal pigment epithelial atrophy and intraretinal pigment migration. Optical coherence tomography of the macula demonstrated complete preservation of the inner segment ellipsoid band in 1 patient, with variable lateral extent in the other patients corresponding to the diameter of a paracentral ring of increased fundus autofluorescence. Electrophysiologic testing in 6 patients confirmed a rod-cone dystrophy phenotype. Molecular investigations identified a previously reported missense variant (p.[N986I]) and 7 variants not previously reported in disease including 4 nonsense (p.[(Q88*], p.[Q222*], p.[Q318*], and p.[R729*]), 2 frameshift (p.[A1048fs13], p.[L849Afs3]), and a splice site variant (c.761 + 2T>A).
The data from this study suggest that visual acuity and foveal structure in patients with RP are preserved into adult life such that a lengthy window of opportunity should exist for intervention with novel therapies.
关于与CNGB1基因变异相关的视网膜色素变性(RP)的表型,已发表的数据有限。这些数据对于患者的预后咨询以及理解潜在的治疗窗口期均十分必要。
描述一系列携带可能致病的CNGB1基因变异的RP患者的详细临床和分子遗传学发现。
设计、地点和参与者:在这个病例系列中,来自9个家庭的10名患者接受了全面的眼科检查。分子研究包括对6名患者进行全外显子组分析。该研究于2013年4月17日至2016年3月3日进行,最终随访于2016年3月2日完成,数据于2014年10月27日至2016年3月29日进行分析。
CNGB1的眼科检查结果和分子遗传学分析。
在这个病例系列中,本研究纳入了来自9个家庭的7名女性和3名男性,平均(标准差)年龄为47.4(13.2)岁,均被鉴定为携带CNGB1基因变异;平均(标准差)随访时长为3.7(2.8)年。首次临床表现为儿童期夜盲,随后在平均(标准差)33.2(8.0)岁时记录到视野缺损。所有患者成年后最佳矫正视力均得以保留,每只眼睛的平均对数最小分辨角视力(logMAR)为0.1(Snellen视力相当于20/25)(右眼logMAR范围为0.0至0.3 [Snellen 20/20至20/40],左眼为-0.1至0.3 [Snellen 20/16至20/40])。眼底检查显示中周边视网膜色素上皮萎缩和视网膜内色素迁移。黄斑区光学相干断层扫描显示1例患者的内节椭圆体带完全保留,其他患者的外侧范围各异,与中心旁眼底自发荧光增强环的直径相对应。6例患者的电生理测试证实为视杆 - 视锥营养不良表型。分子研究鉴定出一个先前报道的错义变异(p.[N986I])和7个疾病中先前未报道的变异,包括4个无义变异(p.[(Q88*]、p.[Q222*]、p.[Q318*]和p.[R729*])以及2个移码变异(p.[A1048fs13]、p.[L849Afs3])和一个剪接位点变异(c.761 + 2T>A)。
本研究数据表明,RP患者的视力和黄斑结构在成年期得以保留,因此对于新疗法的干预应存在较长的机会窗口。